<DOC>
	<DOCNO>NCT00524849</DOCNO>
	<brief_summary>The primary objective study evaluate effect Zometa ( zoledronic acid , 1 mg per week versus 4 mg every four week ) circulate vascular endothelial growth factor ( VEGF ) level breast cancer patient bone metastasis . Sixty patient randomize two group .</brief_summary>
	<brief_title>Zometa Circulating Vascular Endothelial Growth Factor ( VEGF ) Breast Cancer Patients With Bone Metastasis</brief_title>
	<detailed_description>The administration Zometa short interval imply potent maximize antitumor antiangiogenesis effect , dose every four week appropriate strategy prevention management bone metastases . This study design explore relationship dose Zometa level circulate VEGF .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Signed informed consent Female , 18 year old Histologically confirm invasive breast cancer Bone metastases ECOG Performance Status 0 2 Life expectancy 3 month Subject must adequate organ function : Cr ≤ 3 mg/dL ( 265 µmol/L ) ， CrCl ( Cockcroft &amp; Gault ) ≥ 30 mL/min， Ca2+ &gt; 8.0 mg/dL ( 2.0 mmol/L ) ≤ 12 mg/dL ( 3.0 mmol/L ) Negative serum pregnancy test woman childbearing potential Good condition infusion willing undergo phlebotomy whole study Have cease antitumor treatment include chemotherapy , endocrinotherapy biotargeted therapy 28 day Pregnant lactate female History malignancy . However , subject diseasefree 5 year , subject history completely resect nonmelanoma skin cancer successfully treat situ carcinoma eligible . Concurrent disease condition would make subject inappropriate study participation , serious medical disorder would interfere subject 's safety Active uncontrolled infection Current active dental problem include infection teeth jawbone ( maxilla mandible ) ; dental fixture trauma ; current prior diagnosis osteonecrosis jaw ( ONJ ) ; expose bone mouth ; slow healing dental procedure Recent ( within 6 week Randomization ) plan dental jaw surgery ( e.g . extraction , implant ) Known history uncontrolled symptomatic angina , arrhythmia , congestive heart failure Concomitant liver , brain symptomatic lung metastasis ( symptoms hemoptysis , severe cough shortness breath ) Accepted radiotherapy solitary bone disease within 30 day study Previous treatment bisphosphonates radionuclides within one month study Known hypersensitivity bisphosphonates History treatment calcitonin , gallium nitrate mithracin within 14 day study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Bone metastasis</keyword>
	<keyword>Circulating VEGF</keyword>
	<keyword>Zoledronic acid</keyword>
	<keyword>Angiogenesis</keyword>
</DOC>